These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25438145)

  • 1. Post-thaw non-cultured and post-thaw cultured equine cord blood mesenchymal stromal cells equally suppress lymphocyte proliferation in vitro.
    Williams LB; Tessier L; Koenig JB; Koch TG
    PLoS One; 2014; 9(12):e113615. PubMed ID: 25438145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic and immunomodulatory properties of equine cord blood-derived mesenchymal stromal cells.
    Tessier L; Bienzle D; Williams LB; Koch TG
    PLoS One; 2015; 10(4):e0122954. PubMed ID: 25902064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equine platelet lysate as an alternative to fetal bovine serum in equine mesenchymal stromal cell culture - too much of a good thing?
    Russell KA; Koch TG
    Equine Vet J; 2016 Mar; 48(2):261-4. PubMed ID: 25772755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditioned umbilical cord tissue provides a natural three-dimensional storage compartment as in vitro stem cell niche for human mesenchymal stroma/stem cells.
    Yang Y; Melzer C; Bucan V; von der Ohe J; Otte A; Hass R
    Stem Cell Res Ther; 2016 Feb; 7():28. PubMed ID: 26869167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryopreservation of umbilical cord mesenchymal cells in xenofree conditions.
    de Lima Prata K; de Santis GC; Orellana MD; Palma PV; Brassesco MS; Covas DT
    Cytotherapy; 2012 Jul; 14(6):694-700. PubMed ID: 22519634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stromal cells augment CD4+ and CD8+ T-cell proliferation through a CCL2 pathway.
    Zhou Y; Day A; Haykal S; Keating A; Waddell TK
    Cytotherapy; 2013 Oct; 15(10):1195-207. PubMed ID: 23845188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T-Cell Mediated Apoptosis Which Is Partly Rescued by IFNγ Licensing.
    Chinnadurai R; Copland IB; Garcia MA; Petersen CT; Lewis CN; Waller EK; Kirk AD; Galipeau J
    Stem Cells; 2016 Sep; 34(9):2429-42. PubMed ID: 27299362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanded cryopreserved mesenchymal stromal cells as an optimal source for graft-versus-host disease treatment.
    Holubova M; Lysak D; Vlas T; Vannucci L; Jindra P
    Biologicals; 2014 May; 42(3):139-44. PubMed ID: 24548911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of starting material (fresh versus cryopreserved marrow) on mesenchymal stem cell culture.
    Kaplan A; Sackett K; Sumstad D; Kadidlo D; McKenna DH
    Transfusion; 2017 Sep; 57(9):2216-2219. PubMed ID: 28653392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstitution and post-thaw storage of cryopreserved human mesenchymal stromal cells: Pitfalls and optimizations for clinically compatible formulants.
    Aabling RR; Alstrup T; Kjær EM; Poulsen KJ; Pedersen JO; Revenfeld AL; Møller BK; Eijken M
    Regen Ther; 2023 Jun; 23():67-75. PubMed ID: 37153832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryopreservation of equine mesenchymal stem cells in 95% autologous serum and 5% DMSO does not alter post-thaw growth or morphology in vitro compared to fetal bovine serum or allogeneic serum at 20 or 95% and DMSO at 10 or 5.
    Mitchell A; Rivas KA; Smith R; Watts AE
    Stem Cell Res Ther; 2015 Nov; 6():231. PubMed ID: 26611913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro testing of immunosupressive effects of mesenchymal stromal cells on lymphocytes stimulated with alloantigens.
    Lysak D; Vlas T; Holubova M; Miklikova M; Jindra P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):215-9. PubMed ID: 24077235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell RNA-seq of out-of-thaw mesenchymal stromal cells shows tissue-of-origin differences and inter-donor cell-cycle variations.
    Medrano-Trochez C; Chatterjee P; Pradhan P; Stevens HY; Ogle ME; Botchwey EA; Kurtzberg J; Yeago C; Gibson G; Roy K
    Stem Cell Res Ther; 2021 Nov; 12(1):565. PubMed ID: 34736534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to Intravenous Allogeneic Equine Cord Blood-Derived Mesenchymal Stromal Cells Administered from Chilled or Frozen State in Serum and Protein-Free Media.
    Williams LB; Co C; Koenig JB; Tse C; Lindsay E; Koch TG
    Front Vet Sci; 2016; 3():56. PubMed ID: 27500136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intradermal injections of equine allogeneic umbilical cord-derived mesenchymal stem cells are well tolerated and do not elicit immediate or delayed hypersensitivity reactions.
    Carrade DD; Affolter VK; Outerbridge CA; Watson JL; Galuppo LD; Buerchler S; Kumar V; Walker NJ; Borjesson DL
    Cytotherapy; 2011 Nov; 13(10):1180-92. PubMed ID: 21899391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing.
    François M; Copland IB; Yuan S; Romieu-Mourez R; Waller EK; Galipeau J
    Cytotherapy; 2012 Feb; 14(2):147-52. PubMed ID: 22029655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem/stromal cell quality control: validation of mixed lymphocyte reaction assay using flow cytometry according to ICH Q2(R1).
    Nicotra T; Desnos A; Halimi J; Antonot H; Reppel L; Belmas T; Freton A; Stranieri F; Mebarki M; Larghero J; Cras A; Faivre L
    Stem Cell Res Ther; 2020 Oct; 11(1):426. PubMed ID: 33004063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune properties of human umbilical cord Wharton's jelly-derived cells.
    Weiss ML; Anderson C; Medicetty S; Seshareddy KB; Weiss RJ; VanderWerff I; Troyer D; McIntosh KR
    Stem Cells; 2008 Nov; 26(11):2865-74. PubMed ID: 18703664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibitory effects of human bone marrow mesenchymal stem cells and cord blood mononuclear cells on mixed lymphocyte response and PHA induction transformation].
    Wei XF; Liu KY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):261-4. PubMed ID: 15228646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing in vitro conditions for immunomodulation and expansion of mesenchymal stromal cells.
    Samuelsson H; Ringdén O; Lönnies H; Le Blanc K
    Cytotherapy; 2009; 11(2):129-36. PubMed ID: 19152151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.